stoxline Quote Chart Rank Option Currency Glossary
  
Sonendo, Inc. (SONX)
0.0735  -0.004 (-4.79%)    07-19 12:51
Open: 0.0715
High: 0.0735
Volume: 43,250
  
Pre. Close: 0.0772
Low: 0.0715
Market Cap: 5(M)
Technical analysis
2024-07-19 2:54:28 PM
Short term     
Mid term     
Targets 6-month :  0.09 1-year :  0.11
Resists First :  0.08 Second :  0.09
Pivot price 0.07
Supports First :  0.05 Second :  0.04
MAs MA(5) :  0.07 MA(20) :  0.07
MA(100) :  0.1 MA(250) :  0.34
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  60.6 D(3) :  53.5
RSI RSI(14): 43.9
52-week High :  1.47 Low :  0.04
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SONX ] has closed above bottom band by 43.7%. Bollinger Bands are 68.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.08 - 0.08 0.08 - 0.08
Low: 0.08 - 0.08 0.08 - 0.08
Close: 0.08 - 0.08 0.08 - 0.08
Company Description

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

Headline News

Wed, 08 May 2024
Sonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset Priorities - Business Wire

Tue, 12 Mar 2024
Sonendo Inc. on the Brink: NYSE Suspension and Delisting Risks Shake Investor Confidence - TipRanks

Fri, 08 Mar 2024
Sonendo Announces Departure of Chief Financial Officer - Business Wire

Mon, 04 Mar 2024
Sonendo Divests TDO® Software and Amends Credit Agreement - Business Wire

Tue, 09 Jan 2024
Sonendo Continues Expanding the Reach of Its GentleWave Procedure; Partners with Dental Purchasing Group - Business Wire

Tue, 21 Nov 2023
Sonendo Delisted from NYSE - Orange County Business Journal

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 70 (M)
Shares Float 61 (M)
Held by Insiders 10.4 (%)
Held by Institutions 19.4 (%)
Shares Short 411 (K)
Shares Short P.Month 265 (K)
Stock Financials
EPS -0.63
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.34
Profit Margin -123.9 %
Operating Margin -143.4 %
Return on Assets (ttm) -34 %
Return on Equity (ttm) -123.5 %
Qtrly Rev. Growth -18.8 %
Gross Profit (p.s.) 0
Sales Per Share 0.59
EBITDA (p.s.) -0.68
Qtrly Earnings Growth 0 %
Operating Cash Flow -40 (M)
Levered Free Cash Flow -17 (M)
Stock Valuations
PE Ratio -0.12
PEG Ratio 0
Price to Book value 0.21
Price to Sales 0.12
Price to Cash Flow -0.14
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android